Trump nominates Heidi Overton as FDA commissioner amid internal resistance
President Donald Trump announced Heidi Overton, a physician and deputy assistant for domestic policy, as his nominee to lead the Food and Drug Administration. Overton previously served as chief policy officer at the America First Policy Institute and has been a regular presence in Oval Office health briefings. Her nomination comes after former commissioner Marty Makary resigned, leaving Kyle Diamantas as acting commissioner.
While some members of the Make America Healthy Again movement have voiced opposition to the pick, the White House says her interagency coordination work and scientific background qualify her for the role. Senate officials are reviewing the nomination amid questions about her experience managing a large agency.
Why it matters
The FDA commissioner shapes the approval and regulation of medicines and medical devices that affect everyday health decisions.
How the sides frame it
MODERATE AGREEMENTLeft-leaning coverage stresses Overton’s anti-abortion activism and potential politicization of the FDA, while center coverage focuses on questions about her managerial experience and vaccine-policy involvement; Right-leaning coverage highlights her loyalty, pro-life credentials, and promises to speed new treatments.
LEFT
Frames the nomination as a threat to reproductive rights and scientific integrity, emphasizing Overton’s anti-abortion activism and lack of agency experience.
CENTER
Frames the nomination as raising questions about Overton’s limited management experience and involvement in controversial vaccine-policy orders.
RIGHT
Frames the nomination positively, stressing her loyalty, pro-life stance, and commitment to accelerate medical innovations and advance the Make America Healthy Again agenda.
The left emphasises
- anti-abortion activist
- politicize the agency’s scientific mission
- celebrated the Supreme Court’s reversal of Roe v. Wade
The right emphasises
- pro-life views
- "rockstar"
- speed new treatments
How this story developed
- Aug 19 Trump likely to tap White House health aide Heidi Overton as FDA chief
- Aug 20 Trump officially announced Overton as his nominee for FDA commissioner.
- Aug 25 MAHA activists have publicly opposed Overton's nomination.
Related stories
5 in this thread